CASE Op-Ed in DC Journal: The Biden-Harris IRA Anniversary Is Nothing To Celebrate
Two years after President Joe Biden signed the Inflation Reduction Act (IRA) into law, the grim reality of its...
Biden Claims Victory as Medical Innovation is Threatened
October 4, 2023 President Biden announced yesterday that the makers of the first 10 drugs selected for so-called Medicare...
The Small Molecule Penalty Mindlessly Pulls the Brake on Medical Innovation
September 13, 2023 (Alexandria, Virginia) — Today Consumer Action for a Strong Economy (CASE), urged the House Committee on...
Biden Administration Gets its Way – American Healthcare Pays the Price
August 29, 2023 Today, the Centers for Medicare & Medicaid Services (CMS) released their list of the first 10...
CASE Op-Ed – RealClearHealth: Biden Administration Is Using Inflation to Masquerade Their Drug Pricing Schemes
July 26, 2022 The midterms are less than five months away, and with President Biden’s approval numbers at a historic...
CASE Issues Statement & Letter to Senate on Danger of Democrats’ Latest Drug Pricing Plan
July 21, 2022 Today, Gerard Scimeca, Chairman of Consumer Action for a Strong Economy, issued the following statement and...
Democrats’ Drug Pricing Plan: A Step in the Wrong Direction for America’s Seniors
July 6, 2022 After months and months of petty negotiations over Build Back Better, Democrats have finalized a dangerous...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/